glp-1 kidney outcomes news Receptor Agonist Use in Transplant Recipients in: Kidney Volume 17 Issue 8 (2025) Real-World Evidence for GLP-1 Receptor

[2] Dulaglutide (Trulicity), another once-weekly injectable GLP-1 agonist, demonstrates a somewhat more favourable gastrointestinal tolerability profile in some studies, with nausea reported in approximately 8-12% of patients at lower doses, though rates increase with higher doses (3

This method avoids digestion and improves absorption

Vitamin C aids in the healing process by promoting cell regeneration and supporting the skin's natural barrier

Other medications, such as dopamine receptor agonists and anticholinergics, also have limitations, including impulse-control disorders and various anticholinergic side effects (11, 12)